Pulse Biosciences, Inc. PLSE
Set alert
54.09 USD +1.19 +2.25%
As of Nov 3, 12:07 PM ET
53.42 Day range 55.20
12.56 52-week range 58.90
- YTD
- +293.95%
- 1 year
- +222.16%
- Open
- 53.42
- Prev close
- 52.90
- Mkt cap
- 3.86B
- Vol
- 59.60K
- Avg vol
- 501.83K
- EPS
- -1.18
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 53.42
- High
- 55.20
- Forward P/E
- -45.21
- Beta
- 1.64
- Short ratio
- 5.88
- Inst. own
- 15.33%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 51.08
- 200-d avg
- 31.35
- 1y target
- 62.33
MAX chart
Events in this range
- Nov 5, 2025Earnings: -0.29; estimate -0.31; surprise 6.45%
- May 4, 2026Earnings: -0.27; estimate -0.32; surprise 15.62%
- Aug 6, 2026Earnings: -0.36; estimate -0.31; surprise -16.13%
- Oct 6, 2026Rating: Canaccord Genuity · Buy → Buy
- Nov 5, 2026Earnings: —; estimate -0.3095; surprise —%
Signals (36)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| SMA: Bullish | Feb 1, 2026 | 9 months ago |
| SMA: Bearish | Oct 1, 2025 | 1 year ago |
| SMA: Bullish | Sep 1, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 1, 2025 | 1 year ago |
| SMA: Bearish | Mar 1, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2024 | 2 years ago |
| SMA: Bearish | Apr 1, 2024 | 2 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| SMA: Bullish | Nov 1, 2023 | 3 years ago |
| SMA: Bearish | Sep 1, 2023 | 3 years ago |
| MACD: Buy Signal | Apr 1, 2023 | 3 years ago |
| SMA: Bullish | Dec 1, 2022 | 3 years ago |
| SMA: Bearish | Dec 1, 2021 | 4 years ago |
| MACD: Sell Signal | Dec 1, 2021 | 4 years ago |
| SMA: Bearish | Sep 1, 2021 | 5 years ago |
| SMA: Bullish | Aug 1, 2021 | 5 years ago |
| SMA: Bearish | May 1, 2021 | 5 years ago |
| RSI: Overbought | Jan 1, 2021 | 5 years ago |
Newest 20 of 36.
Financial health
Altman Z-Score
133.48 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 1
Valuation
P/E -12.7×
FY 2016 5y median -12.7× FY 2025
P/S 2644×
FY 2016 5y median 134× FY 2025
P/B 11.5×
FY 2016 5y median 11.5× FY 2025
P/FCF -17.0×
FY 2016 5y median -17.0× FY 2025
EV/EBITDA -11.9×
FY 2016 5y median -11.9× FY 2025
EV/Sales 2435×
FY 2016 5y median 155× FY 2025
FCF Yield -5.9%
FY 2016 5y median -5.9% FY 2025
Profitability
Gross Margin -360.0%
FY 2016 5y median -38.8% FY 2025
Operating Margin -21982.6%
FY 2016 5y median -4443.9% FY 2025
Net Margin -20794.6%
FY 2016 5y median -4489.4% FY 2025
ROE -90.2%
FY 2016 5y median -90.2% FY 2025
ROIC -85.7%
FY 2016 5y median -81.4% FY 2025
ROA -75.7%
FY 2016 5y median -75.1% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2016 FY 2025
Operating Income -36.8%
FY 2016 FY 2025
EPS (diluted) -17.4%
FY 2016 FY 2025
Free Cash Flow -49.3%
FY 2016 FY 2025
Financial Health
Current Ratio 10.5×
FY 2016 5y median 10.4× FY 2025
Quick Ratio 10.5×
FY 2016 5y median 10.4× FY 2025
Debt / Equity 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 1.0×
FY 2016 5y median 0.9× FY 2025
Interest Coverage 0.0×
FY 2016 5y median -39.6× FY 2025
Dividends
Dividend Yield 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31
